Publication date: Jul 05, 2023
Adolescents and youths are a key part of the population that needs to be protected against the coronavirus disease 2019 (COVID-19). This is because they are more likely to spread the virus to vulnerable individuals. In view of these concerns, this study investigated the uptake of COVID-19 vaccines and associated factors among adolescents and youths attending secondary schools in Zambia. This cross-sectional study was conducted among 1500 school-going adolescents in Lusaka from September 2022 to November 2022. Overall, 1409 participants took part giving a response rate of 94%. Only 29. 2% (n = 411) of the participants were vaccinated against COVID-19 at the time of the study. Compared to their unvaccinated counterparts, vaccinated adolescents and youths scored higher for knowledge (66. 2% vs 57. 8%) and attitudes (76. 7% vs 39. 4%) regarding COVID-19 vaccines. Healthcare workers, family/friends and social media were key sources of information regarding the vaccine. Factors associated with increased vaccine uptake were positive attitudes (AOR = 33. 62, 95% CI: 19. 92-56. 73), indicating it was stressful to follow COVID-19 preventive measures (AOR = 1. 47, 95% CI: 1. 09-1. 99), participants in Grade 12 (AOR = 3. 39, 95% CI: 1. 94-5. 91), Grade 11 (AOR = 2. 59, 95% CI: 1. 94-5. 91), Grade 10 (AOR = 3. 48, 95% CI: 1. 98-6. 11) and Grade 9 (AOR = 3. 04, 95% CI: 1. 74-5. 32) compared to Grade 8. This study found a relatively low uptake of COVID-19 vaccines among adolescents and youths in Zambia. There is a need to provide adequate strategies to address knowledge and attitude gaps regarding COVID-19 vaccines to improve uptake and reduce future morbidity and mortality.
Open Access PDF
Concepts | Keywords |
---|---|
Coronavirus | Adolescents |
Friends | Aor |
Healthcare | Ci |
November | Covid |
Zambia | Factors |
Future | |
Grade | |
Key | |
Participants | |
Uptake | |
Vaccinated | |
Vaccine | |
Vaccines | |
Youths | |
Zambia |
Semantics
Type | Source | Name |
---|---|---|
disease | VO | COVID-19 vaccine |
disease | VO | vaccination |
disease | VO | population |
disease | MESH | coronavirus disease 2019 |
disease | VO | vaccinated |
disease | VO | time |
disease | VO | unvaccinated |
disease | VO | vaccine |
disease | MESH | morbidity |
drug | DRUGBANK | Adenosine |
drug | DRUGBANK | Coenzyme M |
pathway | REACTOME | Reproduction |
disease | VO | effective |
disease | MESH | infection |
disease | VO | effectiveness |
disease | IDO | pathogen |
disease | MESH | infectious diseases |
disease | VO | USA |
disease | MESH | death |
disease | IDO | country |
disease | MESH | education Levels |
drug | DRUGBANK | Ranitidine |
disease | IDO | process |